Nuclear topoisomerase II activity changes during HL-60 leukemic cell differentiation: Alterations in drug sensitivity and ph dependency

Frank Gieseler*, Fritz Boege, Harald Biersack, Birgit Spohn, Michael Clark, Klaus Wilms

*Korrespondierende/r Autor/-in für diese Arbeit
6 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Nuclear topoisomerase II activity changes during HL-60 leukemic cell differentiation: Alterations in drug sensitivity and ph dependency“. Zusammen bilden sie einen einzigartigen Fingerprint.

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science